A detailed history of Scott Investment Partners LLP transactions in Amgen Inc stock. As of the latest transaction made, Scott Investment Partners LLP holds 3,200 shares of AMGN stock, worth $840,479. This represents 1.98% of its overall portfolio holdings.

Number of Shares
3,200
Previous 3,200 -0.0%
Holding current value
$840,479
Previous $710,000 21.13%
% of portfolio
1.98%
Previous 1.6%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 28, 2021

BUY
$216.38 - $257.67 $692,416 - $824,544
3,200 New
3,200 $736,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $140B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Scott Investment Partners LLP Portfolio

Follow Scott Investment Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scott Investment Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Scott Investment Partners LLP with notifications on news.